These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 24526742)

  • 1. Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.
    McElroy AK; Erickson BR; Flietstra TD; Rollin PE; Nichol ST; Towner JS; Spiropoulou CF
    J Infect Dis; 2014 Aug; 210(4):558-66. PubMed ID: 24526742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker correlates of survival in pediatric patients with Ebola virus disease.
    McElroy AK; Erickson BR; Flietstra TD; Rollin PE; Nichol ST; Towner JS; Spiropoulou CF
    Emerg Infect Dis; 2014 Oct; 20(10):1683-90. PubMed ID: 25279581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned.
    Borchert M; Mutyaba I; Van Kerkhove MD; Lutwama J; Luwaga H; Bisoborwa G; Turyagaruka J; Pirard P; Ndayimirije N; Roddy P; Van Der Stuyft P
    BMC Infect Dis; 2011 Dec; 11():357. PubMed ID: 22204600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome.
    Towner JS; Rollin PE; Bausch DG; Sanchez A; Crary SM; Vincent M; Lee WF; Spiropoulou CF; Ksiazek TG; Lukwiya M; Kaducu F; Downing R; Nichol ST
    J Virol; 2004 Apr; 78(8):4330-41. PubMed ID: 15047846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Feb; 50(5):73-7. PubMed ID: 11686289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004.
    Onyango CO; Opoka ML; Ksiazek TG; Formenty P; Ahmed A; Tukei PM; Sang RC; Ofula VO; Konongoi SL; Coldren RL; Grein T; Legros D; Bell M; De Cock KM; Bellini WJ; Towner JS; Nichol ST; Rollin PE
    J Infect Dis; 2007 Nov; 196 Suppl 2():S193-8. PubMed ID: 17940949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda.
    MacNeil A; Farnon EC; Wamala J; Okware S; Cannon DL; Reed Z; Towner JS; Tappero JW; Lutwama J; Downing R; Nichol ST; Ksiazek TG; Rollin PE
    Emerg Infect Dis; 2010 Dec; 16(12):1969-72. PubMed ID: 21122234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand factor is elevated in individuals infected with Sudan virus and is associated with adverse clinical outcomes.
    McElroy AK; Erickson BR; Flietstra TD; Rollin PE; Towner JS; Nichol ST; Spiropoulou CF
    Viral Immunol; 2015 Feb; 28(1):71-3. PubMed ID: 25387000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filovirus outbreak detection and surveillance: lessons from Bundibugyo.
    MacNeil A; Farnon EC; Morgan OW; Gould P; Boehmer TK; Blaney DD; Wiersma P; Tappero JW; Nichol ST; Ksiazek TG; Rollin PE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S761-7. PubMed ID: 21987748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels.
    Sanchez A; Lukwiya M; Bausch D; Mahanty S; Sanchez AJ; Wagoner KD; Rollin PE
    J Virol; 2004 Oct; 78(19):10370-7. PubMed ID: 15367603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008.
    Wamala JF; Lukwago L; Malimbo M; Nguku P; Yoti Z; Musenero M; Amone J; Mbabazi W; Nanyunja M; Zaramba S; Opio A; Lutwama JJ; Talisuna AO; Okware SI
    Emerg Infect Dis; 2010 Jul; 16(7):1087-92. PubMed ID: 20587179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit.
    Zaki SR; Shieh WJ; Greer PW; Goldsmith CS; Ferebee T; Katshitshi J; Tshioko FK; Bwaka MA; Swanepoel R; Calain P; Khan AS; Lloyd E; Rollin PE; Ksiazek TG; Peters CJ
    J Infect Dis; 1999 Feb; 179 Suppl 1():S36-47. PubMed ID: 9988163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001).
    Lamunu M; Lutwama JJ; Kamugisha J; Opio A; Nambooze J; Ndayimirije N; Okware S
    Int J Infect Dis; 2004 Jan; 8(1):27-37. PubMed ID: 14690778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of Ebola haemorrhagic fever, Uganda, August 2000-January 2001.
    Wkly Epidemiol Rec; 2001 Feb; 76(6):41-6. PubMed ID: 11233580
    [No Abstract]   [Full Text] [Related]  

  • 15. Ebola virus outbreaks in Africa: past and present.
    Muyembe-Tamfum JJ; Mulangu S; Masumu J; Kayembe JM; Kemp A; Paweska JT
    Onderstepoort J Vet Res; 2012 Jun; 79(2):451. PubMed ID: 23327370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients.
    Rosenke K; Adjemian J; Munster VJ; Marzi A; Falzarano D; Onyango CO; Ochieng M; Juma B; Fischer RJ; Prescott JB; Safronetz D; Omballa V; Owuor C; Hoenen T; Groseth A; Martellaro C; van Doremalen N; Zemtsova G; Self J; Bushmaker T; McNally K; Rowe T; Emery SL; Feldmann F; Williamson BN; Best SM; Nyenswah TG; Grolla A; Strong JE; Kobinger G; Bolay FK; Zoon KC; Stassijns J; Giuliani R; de Smet M; Nichol ST; Fields B; Sprecher A; Massaquoi M; Feldmann H; de Wit E
    Clin Infect Dis; 2016 Oct; 63(8):1026-33. PubMed ID: 27531847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An outbreak of Ebola in Uganda.
    Okware SI; Omaswa FG; Zaramba S; Opio A; Lutwama JJ; Kamugisha J; Rwaguma EB; Kagwa P; Lamunu M
    Trop Med Int Health; 2002 Dec; 7(12):1068-75. PubMed ID: 12460399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated L-threonine is a biomarker for Lassa fever and Ebola.
    Gale TV; Schieffelin JS; Branco LM; Garry RF; Grant DS
    Virol J; 2020 Nov; 17(1):188. PubMed ID: 33243278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine and chemokine expression in humans infected with Sudan Ebola virus.
    Hutchinson KL; Rollin PE
    J Infect Dis; 2007 Nov; 196 Suppl 2():S357-63. PubMed ID: 17940971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008.
    Roddy P; Howard N; Van Kerkhove MD; Lutwama J; Wamala J; Yoti Z; Colebunders R; Palma PP; Sterk E; Jeffs B; Van Herp M; Borchert M
    PLoS One; 2012; 7(12):e52986. PubMed ID: 23285243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.